phase ii

  1. Sly Saint

    Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions

    Several posts have been moved from this thread: Ampligen - Hemispherx Biopharma re ME/CFS not relating to ME but Covid-19 AIM ImmunoTech inks deal to research vaping device as a vehicle for Ampligen to treat coronavirus...
  2. Kalliope

    Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study - 2020 - Rekeland, Mella, Fluge et al

    published in frontiers in Medicine - Family Medicine and Primary Care Results: The overall response rate by Fatigue score was 55.0% (22 of 40 patients). Fatigue score and other outcome variables showed significant improvements compared to baseline. The SF-36 Physical Function score increased...
Back
Top Bottom